We are live on ! Find out more
TNGX icon

Tango Therapeutics
TNGX

36 hedge funds and large institutions have $148M invested in Tango Therapeutics in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less capital invested

Capital invested by funds: $150M → $148M (-$2.13M)

1.46% less ownership

Funds ownership: 63.87% → 62.41% (-1.5%)

8% less funds holding

Funds holding: 39 → 36 (-3)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
4
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$1.73M
2
HM
HealthCor Management
New York
+$472K
3
BFM
Boothbay Fund Management
New York
+$207K
4
DCM
Driehaus Capital Management
Illinois
+$117K
5
UBS Group
UBS Group
Switzerland
+$19K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.73M
2
SCM
Suvretta Capital Management
New York
-$1.14M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$1.12M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$663K
5
KSCM
Kamunting Street Capital Management
Florida
-$549K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$13.9M – – –
SCA
2
Southpoint Capital Advisors
New York
$9.45M – – –
ACA
3
Avoro Capital Advisors
New York
$8.9M – – –
BI
4
BVF Inc
California
$8.9M – – –
CAM
5
Cormorant Asset Management
Massachusetts
$8.9M – – –
EC
6
EcoR1 Capital
California
$8.9M – – –
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$6.67M – – –
BlackRock
8
BlackRock
New York
$6.67M – – –
RI
9
RTW Investments
New York
$6.67M – – –
WP
10
Woodline Partners
California
$5.6M – – –
BCLSI
11
Bain Capital Life Sciences Investors
Massachusetts
$5.56M – – –
PA
12
Perceptive Advisors
New York
$5.56M – – –
SB
13
Samsara BioCapital
California
$5.56M – – –
VA
14
VR Adviser
New York
$5.56M – – –
TCM
15
Tang Capital Management
California
$5.21M – – –
Alyeska Investment Group
16
Alyeska Investment Group
Illinois
$4.92M -$663K -57,688 -12%
FCMV
17
Foresite Capital Management V
California
$4.45M – – –
DCM
18
Driehaus Capital Management
Illinois
$3.74M +$117K +10,206 +3%
Citadel Advisors
19
Citadel Advisors
Florida
$3.58M -$414 -36 -0%
IC
20
Ikarian Capital
Texas
$3.34M +$1.73M +150,738 +101%
APM
21
Avidity Partners Management
Texas
$3.34M – – –
LGM
22
Logos Global Management
California
$2.22M – – –
CCM
23
Consonance Capital Management
New York
$2M – – –
NCM
24
Nantahala Capital Management
Connecticut
$1.96M -$277K -24,085 -12%
TCM
25
Tenor Capital Management
New York
$1.35M -$328K -28,500 -19%
1
2

TNGX Hedge Fund Activity: Q1 2021 in Review

36 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q1 2021, worth a combined $148M — down 1.4% from $150M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of TNGX and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 4 added.

The largest buyer was Ikarian Capital, adding an estimated $1.73M. The largest seller was Millennium Management, cutting an estimated $1.73M.

  • 36 institutional investors held Tango Therapeutics (TNGX) as of Q1 2021, down from 39 in Q4 2020.
  • Funds reported $148M of Tango Therapeutics stock for Q1 2021, down 1.4% quarter-over-quarter.
  • 3 funds opened new Tango Therapeutics positions in Q1 2021 and 6 closed out, a net change of -3 holders.
  • The largest Tango Therapeutics buyer in Q1 2021 was Ikarian Capital, an estimated $1.73M added.
  • The largest Tango Therapeutics seller in Q1 2021 was Millennium Management, an estimated $1.73M sold.

Based on aggregated 13F filings for Q1 2021.